Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
With
American Cancer Society, Inc.
Pfizer
This six-week feasibility study will evaluate a virtual support and education program among up to 15 Black female breast cancer survivors. Participants will be asked to attend a 90 minute group session once a week for 6 weeks and complete surveys pre and post intervention surveys to ascertain study endpoints. This study is supported by funding from Pfizer and in-kind support from the American Cancer Society, Inc.
Age
22–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female
Self-identified Black or African American race
Age 22-79
Diagnosis of Stage I, II, or III invasive breast cancer
Completed active treatment at least 6 months ago, but within the past five years
Speaks English
You may not be if
Undergoing active treatment (i.e., surgery, chemotherapy, radiation)
Undergoing evaluation for suspected recurrence
Clareo Health | Breast Cancer Survivor Educational Intervention
